NASDAQ: RVMD · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Revolution Medicines Inc.

How Revolution Medicines Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$40.8B

Price

$190.27

P/E

-23.1

EPS (TTM)

$-8.25

1-year return

223.2%

Dividend yield

0.0%

52-week range

$58.57–$221.15

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources